ARIA-EAACI related publications Main scientific publications informing the ARIA-EAACI 2024-2025 guidelines Question Development Benefits and Harms Values and Preferences Cost-Effectiveness Acceptability Planetary Health Artificial Intelligence–Supported Development of Health Guideline Questions Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysisIntranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysisEfficacy and safety of oral antihistamines for allergic rhinitis: Network meta-analysisIntranasal Treatments for Allergic Rhinitis in Preschool- and School-Age Children: Network Meta-Analysis Patients’ values and preferences for health states in allergic rhinitis—An artificial intelligence supported systematic reviewEmbedding patients’ values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024 Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee ReportBehavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world dataAdherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study A Novel Approach to Consider Planetary Health in Guideline Development: A GRADE Approach Using the Allergic Rhinitis and its Impact on Asthma (ARIA) 2024-2025 Guidelines as a Case Study
